Zobrazeno 1 - 10
of 123
pro vyhledávání: '"Johannes Hofland"'
Autor:
Merijn CF Mulders, Anna Vera D Verschuur, Quido G de Lussanet de la Sablonière, Eva Maria Roes, Christoph Geisenberger, Lodewijk AA Brosens, Wouter W deHerder, Marie‐Louise F vanVelthuysen, Johannes Hofland
Publikováno v:
The Journal of Pathology: Clinical Research, Vol 10, Iss 6, Pp n/a-n/a (2024)
Abstract Currently, the available literature provides insufficient support to differentiate between primary ovarian neuroendocrine tumors (PON) and neuroendocrine ovarian metastases (NOM) in patients. For this reason, patients with a well‐different
Externí odkaz:
https://doaj.org/article/15b2ab2709264023a4605e9fd3afed50
Publikováno v:
Endocrine Oncology, Vol 3, Iss 1, Pp 1-15 (2023)
11-oxygenated androgens are a class of steroids capable of activating the androgen receptor (AR) at physiologically relevant concentrations. In view of the AR as a key driver of prostate cancer (PC), these steroids are potential drivers of disease an
Externí odkaz:
https://doaj.org/article/c0a626bef6d74e5b8686ba2ae306a4f5
Autor:
Maria J. Klomp, Julie Refardt, Peter M. van Koetsveld, Claudia Campana, Simone U. Dalm, Fadime Dogan, Marie-Louise F. van Velthuysen, Richard A. Feelders, Wouter W. de Herder, Johannes Hofland, Leo J. Hofland
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2023)
BackgroundSomatostatin receptor type 2 (SST2) expression is critical for the diagnosis and treatment of neuroendocrine tumors and is associated with improved patient survival. Recent data suggest that epigenetic changes such as DNA methylation and hi
Externí odkaz:
https://doaj.org/article/7942dd91c0ec4a4293b961afd26f2d10
Autor:
Emile B. Veenstra, Adrienne H. Brouwers, Derk Jan A. de Groot, Johannes Hofland, Annemiek M. E. Walenkamp, Tessa Brabander, Wouter T. Zandee, Walter Noordzij
Publikováno v:
European Journal of Hybrid Imaging, Vol 6, Iss 1, Pp 1-11 (2022)
Abstract Background In treatment of neuroendocrine neoplasms (NENs), confirmation of somatostatin receptor expression with 68Ga-DOTA somatostatin analogues is mandatory to determine eligibility for peptide receptor radionuclide therapy (PRRT). [18F]D
Externí odkaz:
https://doaj.org/article/1a243b2f663f4ad9a388ef25fd899542
Autor:
Anela Blažević, Anand M Iyer, Marie-Louise F van Velthuysen, Johannes Hofland, Peter M van Koestveld, Gaston J H Franssen, Richard A Feelders, Marina Zajec, Theo M Luider, Wouter W de Herder, Leo J Hofland
Publikováno v:
Endocrine Connections, Vol 11, Iss 4, Pp 1-9 (2022)
Background: Increased levels of serotonin secretion are associated with mesenteric fibrosis (MF) in small intestinal neuroendocrine tumors (SI-NETs ). However, the profibrotic potential of serotonin differs between patients, and in this study, we aim
Externí odkaz:
https://doaj.org/article/a8a2a975221440cda43093bc90a8bceb
Autor:
Sander C. Ebbers, Tessa Brabander, Margot E. T. Tesselaar, Johannes Hofland, Manon N. G. J. A. Braat, Frank J. Wessels, Maarten W. Barentsz, Marnix G. E. H. Lam, Arthur J. A. T. Braat
Publikováno v:
EJNMMI Research, Vol 12, Iss 1, Pp 1-13 (2022)
Abstract Purpose In patients with neuroendocrine tumor liver metastases, additional tumor reduction can be achieved by sequential treatment with [166Ho]-radioembolization after peptide receptor radionuclide therapy (PRRT). The aim of this study was t
Externí odkaz:
https://doaj.org/article/a6e5388508fd46a9bcf2c050e2e76238
Autor:
Julie Refardt, Maria J. Klomp, Peter M. vanKoetsveld, Fadime Dogan, Mark Konijnenberg, Tessa Brabander, Richard A. Feelders, Wouter W. deHerder, Leo J. Hofland, Johannes Hofland
Publikováno v:
Clinical and Translational Medicine, Vol 12, Iss 7, Pp n/a-n/a (2022)
Externí odkaz:
https://doaj.org/article/e531d1c7f0f24f7faf60967dbd130de7
Autor:
Joana Lima Ferreira, Bernardo Marques, C Willemien Menke-van der Houven van Oordt, Wouter W de Herder, Tessa Brabander, Johannes Hofland
Publikováno v:
Endocrinology, Diabetes & Metabolism Case Reports, Vol 1, Iss 1, Pp 1-5 (2021)
Middle ear adenomas with neuroendocrine features (ANEF) are rare, with an estimated 150 reported cases. They usually pursue an indolent clinical course. Four reported cases of middle ear ANEF with distant metastases were treated with surgery, externa
Externí odkaz:
https://doaj.org/article/034b76c0cd074ed0be7f28de36a5e883
Autor:
Gido Snaterse, Lisanne F. van Dessel, Job van Riet, Angela E. Taylor, Michelle van der Vlugt-Daane, Paul Hamberg, Ronald de Wit, Jenny A. Visser, Wiebke Arlt, Martijn P. Lolkema, Johannes Hofland
Publikováno v:
JCI Insight, Vol 6, Iss 11 (2021)
BACKGROUND Continued androgen receptor (AR) signaling constitutes a key target for treatment in metastatic castration-resistant prostate cancer (CRPC). Studies have identified 11-ketotestosterone (11KT) as a potent AR agonist, but it is unknown if 11
Externí odkaz:
https://doaj.org/article/ad864ce07470475e827abbccf2201326
Autor:
Hidde A Galema, Tessa M van Ginhoven, Gaston J H Franssen, Johannes Hofland, Claire G O T Bouman, Cornelis Verhoef, Alexander L Vahrmeijer, Merlijn Hutteman, Denise E Hilling, Stijn Keereweer
Publikováno v:
The British journal of surgery, 110(5), 541-544. John Wiley & Sons Ltd.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3052ca93e1b4b35eb3d743476f2e4dd7
https://doi.org/10.1093/bjs/znad043
https://doi.org/10.1093/bjs/znad043